Dr Krishna Yalla

  • Research Associate - Translational Pharmacology Laboratory (Translational Pharmacology Lab)

telephone: 0141 330 3509
email: Krishna.Yalla@glasgow.ac.uk

Room 329, Translational Pharmacology Laboratory, Wolfson Wohl Cancer Research Centre, Switchback Road, Garscube Estate, Glasgow, G61 1QH

Import to contacts

Publications

List by: Type | Date

Jump to: 2022 | 2018 | 2016 | 2014 | 2013 | 2010
Number of items: 9.

2022

Gallagher, P. F. et al. (2022) A CRUK First-in-human Phase I Trial of LY3143921, a Novel CDC7 Inhibitor, in OPatients with Advanced Solid Tumors. 2022 ASCO Annual Meeting I, 03-07 Jun 2022. p. 3103. (doi: 10.1200/JCO.2022.40.16_suppl.3103)

2018

Salomé, M. , Magee, A., Yalla, K., Chaudhury, S. , Sarrou, E. , Carmody, R. J. and Keeshan, K. (2018) A Trib2-p38 axis controls myeloid leukaemia cell cycle and stress response signalling. Cell Death and Disease, 9(5), 443. (doi: 10.1038/s41419-018-0467-3) (PMID:29670085) (PMCID:PMC5906628)

O'Connor, C., Yalla, K., Salome, M. , Moka, H. A., Gómez Castañeda, E., Eyers, P. A. and Keeshan, K. (2018) Trib2 expression in granulocyte-monocyte progenitors drives a highly drug resistant acute myeloid leukaemia linked to elevated Bcl2. Oncotarget, 9(19), pp. 14977-14992. (doi: 10.18632/oncotarget.24525) (PMID:29599919) (PMCID:PMC5871090)

Yalla, K. et al. (2018) FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system. Molecular Psychiatry, 23(5), pp. 1278-1286. (doi: 10.1038/mp.2017.138) (PMID:28727686) (PMCID:PMC5984089)

2016

Yalla, K., O'Connor, C., Campos, J. and Keeshan, K. (2016) TRIB2 Transformed GMP is the Myeloid Leukaemia Initiating Cell. 21st Congress Of The European Hematology Association, Copenhagen, Denmark, 9-12 June 2016.

Tankou, S. et al. (2016) SUMOylation of DISC1: a potential role in neural progenitor proliferation in the developing cortex. Molecular Neuropsychiatry, 2(1), pp. 20-27. (doi: 10.1159/000444257) (PMID:27525255) (PMCID:PMC4979612)

2014

Sheppard, C. L. et al. (2014) Mitotic activation of the DISC1-inducible cyclic AMP phosphodiesterase-4D9 (PDE4D9), through multi-site phosphorylation, influences cell cycle progression. Cellular Signalling, 26(9), pp. 1958-1974. (doi: 10.1016/j.cellsig.2014.04.023)

2013

Cameron, R.T., Coleman, R.G., Day, J.P., Yalla, K.C., Houslay, M.D., Adams, D.R., Shoichet, B.K. and Baillie, G.S. (2013) Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4). Biochemical Pharmacology, 85(9), pp. 1297-1305. (doi: 10.1016/j.bcp.2013.02.026) (PMID:23473803) (PMCID:PMC3625111)

2010

Ritchie, S. A., Kohlhaas, C. F., Boyd, A. R., Yalla, K. C., Walsh, K., Connell, J. M.C. and Salt, I. P. (2010) Insulin-stimulated phosphorylation of endothelial nitric oxide synthase at serine-615 contributes to nitric oxide synthesis. Biochemical Journal, 426(1), pp. 85-90. (doi: 10.1042/BJ20091580)

This list was generated on Tue Apr 16 23:33:11 2024 BST.
Number of items: 9.

Articles

Salomé, M. , Magee, A., Yalla, K., Chaudhury, S. , Sarrou, E. , Carmody, R. J. and Keeshan, K. (2018) A Trib2-p38 axis controls myeloid leukaemia cell cycle and stress response signalling. Cell Death and Disease, 9(5), 443. (doi: 10.1038/s41419-018-0467-3) (PMID:29670085) (PMCID:PMC5906628)

O'Connor, C., Yalla, K., Salome, M. , Moka, H. A., Gómez Castañeda, E., Eyers, P. A. and Keeshan, K. (2018) Trib2 expression in granulocyte-monocyte progenitors drives a highly drug resistant acute myeloid leukaemia linked to elevated Bcl2. Oncotarget, 9(19), pp. 14977-14992. (doi: 10.18632/oncotarget.24525) (PMID:29599919) (PMCID:PMC5871090)

Yalla, K. et al. (2018) FBXW7 regulates DISC1 stability via the ubiquitin-proteosome system. Molecular Psychiatry, 23(5), pp. 1278-1286. (doi: 10.1038/mp.2017.138) (PMID:28727686) (PMCID:PMC5984089)

Tankou, S. et al. (2016) SUMOylation of DISC1: a potential role in neural progenitor proliferation in the developing cortex. Molecular Neuropsychiatry, 2(1), pp. 20-27. (doi: 10.1159/000444257) (PMID:27525255) (PMCID:PMC4979612)

Sheppard, C. L. et al. (2014) Mitotic activation of the DISC1-inducible cyclic AMP phosphodiesterase-4D9 (PDE4D9), through multi-site phosphorylation, influences cell cycle progression. Cellular Signalling, 26(9), pp. 1958-1974. (doi: 10.1016/j.cellsig.2014.04.023)

Cameron, R.T., Coleman, R.G., Day, J.P., Yalla, K.C., Houslay, M.D., Adams, D.R., Shoichet, B.K. and Baillie, G.S. (2013) Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4). Biochemical Pharmacology, 85(9), pp. 1297-1305. (doi: 10.1016/j.bcp.2013.02.026) (PMID:23473803) (PMCID:PMC3625111)

Ritchie, S. A., Kohlhaas, C. F., Boyd, A. R., Yalla, K. C., Walsh, K., Connell, J. M.C. and Salt, I. P. (2010) Insulin-stimulated phosphorylation of endothelial nitric oxide synthase at serine-615 contributes to nitric oxide synthesis. Biochemical Journal, 426(1), pp. 85-90. (doi: 10.1042/BJ20091580)

Conference or Workshop Item

Gallagher, P. F. et al. (2022) A CRUK First-in-human Phase I Trial of LY3143921, a Novel CDC7 Inhibitor, in OPatients with Advanced Solid Tumors. 2022 ASCO Annual Meeting I, 03-07 Jun 2022. p. 3103. (doi: 10.1200/JCO.2022.40.16_suppl.3103)

Yalla, K., O'Connor, C., Campos, J. and Keeshan, K. (2016) TRIB2 Transformed GMP is the Myeloid Leukaemia Initiating Cell. 21st Congress Of The European Hematology Association, Copenhagen, Denmark, 9-12 June 2016.

This list was generated on Tue Apr 16 23:33:11 2024 BST.